Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): A comparison of different promoters

Gene Therapy

Volumn 5, Issue 3, 1998, Pages 352-360

  Sallenave, J M ^a,b   Xing, Z ^a   Simpson, A J ^b   Graham, F L ^a   Gauldie, J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adenovirus; Elafin; Elastase specific inhibitor; Gene therapy; Proteinase inhibitor

Indexed keywords

ELAFIN; ELASTASE INHIBITOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; RAT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; RODENTIA;

EID: 0031885387     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300610     Document Type: Article

References (41)

1. Curiel DT, Pilewski JM, Abelda SM. Gene therapy approaches for inherited and acquired lung diseases. Am J Respir Cell Mol Biol 1996; 14: 1-18.
2. Braciak T et al. Construction of recombinant human type 5 adenovirus expressing rodent IL-6 genes. J Immunol 1993; 151: 5145-5153.
3. Xing Z et al. Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammation. J LeUk Biol 1996; 59: 481-488.
4. Erzurum SC et al. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Res 1993; 21: 1607-1612.
5. Korst RJ, Bewig B, Crystal RG. In vitro and in vivo transfer and expression of human surfactants SP-A and SP-B-associated protein cDNAs mediated by replication-deficient recombinant adenoviral vectors. Hum Gene Ther 1995; 6: 277-287.
6. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant alpha-1 antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
7. Yang Y, Li Q, Hildegrund CJE, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lungdirected gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015
8. Mitani K, Graham FL, Caskey CT, Kochanek S. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci USA 1995; 92: 3854-3858.
9. Fisher KJ et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 1996; 217: 11-22.
10. Yang Y et al. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol 1996; 70: 6370-6377.
11. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med 1995; 1: 890-893.
12. Sallenave JM, Ryle AP. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol Chem Hoppe-Seyler 1991; 372: 13-21.
13. Sallenave JM, Silva A. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am J Respir Cell Mol Biol 1993; 8: 439-445.
14. Sallenave JM, Silva A, Marsden ME, Ryle AP. Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am J Respir Cell Mol Biol 1993; 8: 126-133.
15. Wiedow O et al. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 1990; 265: 14791-14795.
16. Molhuizen HOF et al. SKALP/elafin: an elastase inhibitor from cultured human kerarinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J Biol Chem 1993; 268: 12028-12032.
17. Xu ZZ et al. Investigation of promoter function in human and animal cells infected with human recombinant adenoviruses expressing rotavirus antigen VP7sc. J Gen Virol 1995; 76: 1971-1980.
18. Lafemina RL, Hayward GS. Differences in cell type-specific blocks to immediate-early gene expression and DNA replication of human, simian and murine cytomegalovirus. J Gen Virol 1988; 69: 355-374.
19. Hubbard RC, Brantly ML, Crystal RG. Proteases. In: Crystal RG el al (eds). The Lung. Scientific Foundations, Raven Press: New York, 1991, pp 1763-1773.
20. Laurell CB, Ericksson S. The electrophoretic alpha-1 globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15: 132-140.
21. Sobol RE, Scanlon KJ. The Internet Book of Gene Therapy-Cancer Therapeutics. Appleton and Lange- Stamford, CT, 1995, pp 299-351.
22. Stockley RA et al. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment. Thorax 1986; 41: 442-447.
23. Kramps JA, Franken C, Dijkman JH. Quantity of antileukoprotease relative to alpha-1 proteinase inhibitor in peripheral airspaces of the human lung. Clin Sci 1988; 75: 351-353.
24. Sallenave JM, Marsden MD, Ryle AP. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions: evidence of sequence homology and immunological cross-reactivity. Biol Chem Hoppe-Seyler 1992; 373: 27-33.
25. Sallenave JM et al. Up-regulation of secretory leukocyte protein- ase inhibitor (SLPI) and down-regulation of elafin in pulmonary chronic inflammation. Am J Respir Crit Care Med 1995; 151: A531.
26. Wilkinson GWG, Akrigg A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 1992; 20: 2233-2239.
27. Davidson D, Hassell JA. Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector. J Virol 1987; 61: 1226-1239.
28. Dorsh-Hasler JM et al. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate-early mRNA in murine cytomegalovirus. Proc Natl Acad Sci USA 1985; 82: 8325-8329.
29. Bert AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91: 8802-8806.
30. Kolls J, Peppel K, Silva M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirusmediated gene transfer. Proc Natl Acad Sci USA 1994; 91: 215-219.
31. Xing Z el al. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J Clin Invest 1996; 97: 1102-1110.
32. Kolls J et al. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J Infect Dis 1995; 171: 570-575.
33. Wiedow O, Luademann J, Utecht B. Elafin is a potent inhibitor of proteinase 3. Biochem Biophys Res Commun 1991; 174: 6-10.
34. Kao RC et al. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 1988; 82: 1963-1973.
35. Graham FL, Prevec L. Gene transfer and expression protocols. In: Murray EJ, Walker JM (eds). Methods in Molecular Biology. Humana Press: Clifton, 1991, pp 109-127.
36. Lieber M et al. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976; 17: 62-70.
37. Jordana M et al. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1987; 137: 579-584.
38. Chirgwin JM, Pryzbyla AE, MacDonald RG, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-5299.
39. Sallenave et al. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994; 11: 733-741.
40. Xing Z et al. Adenovirus-mediated cytokine gene transfer at tissue sites. J Immunol 1994; 153: 4059-4069.
41. Xing Z et al. Polymorphonuclear leukocytes as a significant source of tumor necrosis factor in endotoxin-challenged lung tissue. Am J Pathol 1993; 143: 1009-1015.